United States Healthcare Equipment & Supplies

Clearpoint Neuro Inc (CLPT)

Track

Over the last 90 days, Clearpoint Neuro Inc. has seen significant insider selling, with a net value of -$251,340.55. A total of 8 transactions were recorded, all of which were sales. Notably, directors and officers like Joseph M. Burnett and Pascal E. Girin were involved in substantial sell-offs, totaling over $1.6 million.
Stock chart
Ticker: CLPT Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Richards Timothy T.
1 sale — total 100,000 USD
Sale 1 Jun 2026
Value US$1,982,244.08 | Price 21.77 | Shares 14,839
Proposed sale 1 Jun 2026
Value US$4,269,156.43 | Price 366.80 | Shares 64,263
Proposed sale 29 May 2026
Value US$100,000.00 | Price 12.54 | Shares 1,000
Sale 21 May 2026
Value US$100,000.00 | Price 11.59 | Shares 1,000
Proposed sale 21 May 2026
Value US$100,000.00 | Price 11.59 | Shares 1,000
Proposed sale 21 May 2026
Value US$100,000.00 | Price 11.59 | Shares 1,000
Planned sale 20 May 2026
Value US$100,000.00 | Price 11.14 | Shares 1,000
Proposed sale 20 May 2026
Value US$100,000.00 | Price 11.17 | Shares 1,000
Planned sale 25 Feb 2026
Value US$302,656.67 | Price 15.17 | Shares 19,951
Proposed sale 25 Feb 2026
Value US$317,102.70 | Price 14.55 | Shares 21,794
Planned sale 26 Jan 2026
Value US$45,822.51 | Price 15.57 | Shares 2,943
Proposed sale 26 Jan 2026
Value US$46,146.24 | Price 15.68 | Shares 2,943
Proposed sale 9 Jan 2026
Value US$306,200.00 | Price 15.31 | Shares 20,000
Planned sale 9 Jan 2026
Value US$322,400.00 | Price 16.12 | Shares 20,000
Proposed sale 9 Jan 2026
Value US$306,200.00 | Price 15.31 | Shares 20,000
Proposed sale 12 Nov 2025
Value US$14,787,374.34 | Price 16.53 | Shares 894,578
Planned sale 10 Oct 2025
Value US$8,763.00 | Price 29.21 | Shares 300
Planned sale 10 Oct 2025
Value US$56,735.84 | Price 28.64 | Shares 1,981
Planned sale 10 Oct 2025
Value US$182,396.36 | Price 27.64 | Shares 6,599
Planned sale 10 Oct 2025
Value US$466,125.33 | Price 26.51 | Shares 17,583
Proposed sale 10 Oct 2025
Value US$766,368.48 | Price 28.96 | Shares 26,463
Sale 10 Jun 2025
Value US$132,800.00 | Price 13.28 | Shares 10,000
Proposed sale 10 Jun 2025
Value US$132,843.00 | Price 13.28 | Shares 10,000
Sale 9 Jun 2025
Value US$282,372.63 | Price 13.29 | Shares 21,247
Proposed sale 9 Jun 2025
Value US$282,357.76 | Price 13.29 | Shares 21,247
Sale 3 Jun 2025
Value US$15,456.00 | Price 12.88 | Shares 1,200
Sale 3 Jun 2025
Value US$112,770.00 | Price 12.53 | Shares 9,000
Proposed sale 3 Jun 2025
Value US$128,231.34 | Price 12.57 | Shares 10,200
Proposed sale 5 Jun 2023
Value US$3,104,000.00 | Price 7.76 | Shares 400,000
Planned sale 15 Aug 2022
Value US$303,192.69 | Price 16.07 | Shares 18,867
Planned sale 11 Nov 2021
Value US$168,800.00 | Price 16.88 | Shares 10,000
Planned sale 21 Jun 2021
Value US$464,250.00 | Price 18.57 | Shares 25,000
Buy 25 Sep 2018
Value US$31,250.00 | Price 1.25 | Shares 25,000
Buy 24 Aug 2018
Value US$11,850.00 | Price 1.58 | Shares 7,500
Buy 22 Aug 2018
Value US$7,187.35 | Price 1.55 | Shares 4,637
Buy 21 May 2018
Value US$17,902.50 | Price 2.39 | Shares 7,500
Buy 26 May 2017
Value US$0.00 | Price 0.00 | Shares 7,500
Buy 26 May 2017
Value US$0.00 | Price 0.00 | Shares 12,500
Buy 2 Sep 2016
Value US$0.00 | Price 0.00 | Shares 10,000
Buy 2 Sep 2016
Value US$0.00 | Price 0.00 | Shares 20,000
Buy 12 Sep 2014
Value US$7,080.00 | Price 1.18 | Shares 6,000
Buy 12 Sep 2014
Value US$11,800.00 | Price 1.18 | Shares 10,000
Buy 13 Aug 2014
Value US$3,500.00 | Price 1.00 | Shares 3,500
Buy 13 Jun 2014
Value US$21,900.00 | Price 0.73 | Shares 30,000
Buy 10 Jun 2014
Value US$39,210.00 | Price 0.78 | Shares 50,000
Buy 19 Aug 2013
Value US$127,000.00 | Price 1.27 | Shares 100,000
Buy 11 Jun 2013
Value US$46,040.50 | Price 1.10 | Shares 41,855
Buy 13 May 2013
Value US$1,980.00 | Price 1.32 | Shares 1,500
Buy 22 Mar 2013
Value US$3,700.00 | Price 1.48 | Shares 2,500
Buy 20 Mar 2013
Value US$3,450.00 | Price 1.50 | Shares 2,300
Buy 19 Mar 2013
Value US$298.00 | Price 1.49 | Shares 200
Buy 14 Mar 2013
Value US$7,500.00 | Price 1.50 | Shares 5,000
Buy 14 Mar 2013
Value US$7,500.00 | Price 1.50 | Shares 5,000
Buy 14 Mar 2013
Value US$7,500.00 | Price 1.50 | Shares 5,000
Buy 14 Mar 2013
Value US$7,500.00 | Price 1.50 | Shares 5,000
Buy 14 Mar 2013
Value US$5,350.90 | Price 1.46 | Shares 3,665
Buy 14 Mar 2013
Value US$11,250.00 | Price 1.50 | Shares 7,500
Buy 14 Mar 2013
Value US$2,235.00 | Price 1.49 | Shares 1,500
Buy 13 Mar 2013
Value US$3,000.00 | Price 1.50 | Shares 2,000
Buy 11 Mar 2013
Value US$15,000.00 | Price 1.50 | Shares 10,000
Buy 11 Mar 2013
Value US$15,550.00 | Price 1.56 | Shares 10,000
Buy 11 Mar 2013
Value US$5,526.50 | Price 1.58 | Shares 3,500
Buy 11 Mar 2013
Value US$7,827.50 | Price 1.55 | Shares 5,050
Buy 14 Sep 2012
Value US$2,250.00 | Price 2.25 | Shares 1,000
Buy 14 Sep 2012
Value US$2,270.00 | Price 2.27 | Shares 1,000
Buy 14 Sep 2012
Value US$2,250.00 | Price 2.25 | Shares 1,000
Buy 14 Sep 2012
Value US$2,000.00 | Price 2.00 | Shares 1,000
Buy 13 Sep 2012
Value US$5,050.00 | Price 2.02 | Shares 2,500
Buy 13 Sep 2012
Value US$5,000.00 | Price 2.00 | Shares 2,500
Buy 13 Sep 2012
Value US$3,075.00 | Price 2.05 | Shares 1,500
Buy 12 Sep 2012
Value US$5,125.00 | Price 2.05 | Shares 2,500
Buy 12 Sep 2012
Value US$5,250.00 | Price 2.10 | Shares 2,500
Buy 12 Sep 2012
Value US$5,205.00 | Price 2.08 | Shares 2,500
Buy 12 Sep 2012
Value US$9,737.50 | Price 2.05 | Shares 4,750
Buy 11 Sep 2012
Value US$10,250.00 | Price 2.05 | Shares 5,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-02 2026-06-01 S Sale
2.2
Richards Timothy T.
Non-Executive Director
14,839 -48.7%
21.77
US$1,982,244 		14,839 -48.7% 21.77 US$1,982,244
2026-06-01 2026-06-01 PrS Proposed sale
2.2
TIMOTHY RICHARDS

Director

Non-Executive Director
64,263
366.80
US$4,269,156 		64,263 366.80 US$4,269,156
2026-05-29 2026-05-29 PrS Proposed sale
PASCAL E. GIRIN

Director

Non-Executive Director
2,746
417.86
US$3,105,071 		2,746 417.86 US$3,105,071
2026-05-26 2026-05-21 S Sale
3.1
Klein Matthew B.
Non-Executive Director
1,000 -25.4%
11.59
US$100,000 		1,000 -25.4% 11.59 US$100,000
2026-05-21 2026-05-21 PrS Proposed sale
3.1
MATTHEW B KLEIN

Director

Non-Executive Director
1,000
11.59
US$100,000 		1,000 11.59 US$100,000
2026-05-21 2026-05-21 PrS Proposed sale
3.1
MATTHEW B KLEIN

Director

Non-Executive Director
1,000
11.59
US$100,000 		1,000 11.59 US$100,000
2026-05-21 2026-05-20 PlS Planned sale
3.1
FALLON LYNNETTE C
Non-Executive Director
1,000 -9.5%
11.14
US$100,000 		1,000 -9.5% 11.14 US$100,000
2026-05-20 2026-05-20 PrS Proposed sale
3.1
LYNNETTE C FALLON

Director

Non-Executive Director
1,000
11.17
US$100,000 		1,000 11.17 US$100,000
2026-02-26 2026-02-25 PlS Planned sale
2.2
BURNETT JOSEPH

CEO and President

Executive Director
19,951 -9.4%
15.17
US$302,657 		19,951 -9.4% 15.17 US$302,657
2026-02-25 2026-02-25 PrS Proposed sale
2.2
JOSEPH M BURNETT TRUST

Affiliate of Director

Non-Executive Director
21,794
14.55
US$317,103 		21,794 14.55 US$317,103
2026-01-27 2026-01-26 PlS Planned sale
2.2
BURNETT JOSEPH

CEO and President

Executive Director
2,943 -1.4%
15.57
US$45,823 		2,943 -1.4% 15.57 US$45,823
2026-01-26 2026-01-26 PrS Proposed sale
2.2
JOSEPH M BURNETT TRUST

Affiliate of Director

Non-Executive Director
2,943
15.68
US$46,146 		2,943 15.68 US$46,146
2026-02-20 2026-01-09 PrS Proposed sale
2.2
BURNETT JOSEPH

Officer; Director

Executive Director
20,000
15.31
US$306,200 		20,000 15.31 US$306,200
2026-01-13 2026-01-09 PlS Planned sale
2.2
BURNETT JOSEPH

CEO and President

Executive Director
20,000 -63.4%
16.12
US$322,400 		20,000 -63.4% 16.12 US$322,400
2026-01-09 2026-01-09 PrS Proposed sale
2.2
JOSEPH M BURNETT

Director; Officer

Executive Director
20,000
15.31
US$306,200 		20,000 15.31 US$306,200
2025-11-12 2025-11-12 PrS Proposed sale
PTC Therapeutics, Inc.

Affiliate of director

Non-Executive Director
894,578
16.53
US$14,787,374 		894,578 16.53 US$14,787,374
2025-10-14 2025-10-10 PlS Planned sale
2.2
BURNETT JOSEPH

CEO and President

Executive Director
300 -0.1%
29.21
US$8,763 		300 -0.1% 29.21 US$8,763
2025-10-14 2025-10-10 PlS Planned sale
2.2
BURNETT JOSEPH

CEO and President

Executive Director
1,981 -0.9%
28.64
US$56,736 		1,981 -0.9% 28.64 US$56,736
2025-10-14 2025-10-10 PlS Planned sale
2.2
BURNETT JOSEPH

CEO and President

Executive Director
6,599 -2.9%
27.64
US$182,396 		6,599 -2.9% 27.64 US$182,396
2025-10-14 2025-10-10 PlS Planned sale
2.2
BURNETT JOSEPH

CEO and President

Executive Director
17,583 -7.2%
26.51
US$466,125 		17,583 -7.2% 26.51 US$466,125
2025-10-10 2025-10-10 PrS Proposed sale
2.2
JOSEPH M BURNETT TRUST

Affiliate of Director

Non-Executive Director
26,463
28.96
US$766,368 		26,463 28.96 US$766,368
2025-06-12 2025-06-10 S Sale
2.2
Richards Timothy T.
Non-Executive Director
10,000 -11.4%
13.28
US$132,800 		10,000 -11.4% 13.28 US$132,800
2025-06-10 2025-06-10 PrS Proposed sale
2.2
TIMOTHY RICHARDS

Director

Non-Executive Director
10,000
13.28
US$132,843 		10,000 13.28 US$132,843
2025-06-11 2025-06-09 S Sale
2.2
BURNETT JOSEPH

CEO and President

Executive Director
21,247 -8.0%
13.29
US$282,373 		21,247 -8.0% 13.29 US$282,373
2025-06-09 2025-06-09 PrS Proposed sale
2.2
JOSEPH M BURNETT TRUST

Officer; Director

Executive Director
21,247
13.29
US$282,358 		21,247 13.29 US$282,358
2025-06-05 2025-06-03 S Sale
3.1
FALLON LYNNETTE C
Non-Executive Director
1,200 -2.9%
12.88
US$15,456 		1,200 -2.9% 12.88 US$15,456
2025-06-05 2025-06-03 S Sale
3.1
FALLON LYNNETTE C
Non-Executive Director
9,000 -17.6%
12.53
US$112,770 		9,000 -17.6% 12.53 US$112,770
2025-06-03 2025-06-03 PrS Proposed sale
3.1
LYNNETTE FALLON

Director

Non-Executive Director
10,200
12.57
US$128,231 		10,200 12.57 US$128,231
2023-06-05 2023-06-05 PrS Proposed sale
PTC Therapeutics, Inc.

10% Stockholder

Large shareholder
400,000
7.76
US$3,104,000 		400,000 7.76 US$3,104,000
2022-08-16 2022-08-15 PlS Planned sale
2.2
BURNETT JOSEPH MICHAEL

CEO and President

Executive Director
18,867 -6.7%
16.07
US$303,193 		18,867 -6.7% 16.07 US$303,193
2021-11-12 2021-11-11 PlS Planned sale
2.2
BURNETT JOSEPH MICHAEL

CEO and President

Executive Director
10,000 -4.3%
16.88
US$168,800 		10,000 -4.3% 16.88 US$168,800
2021-06-22 2021-06-21 PlS Planned sale
2.2
BURNETT JOSEPH MICHAEL

CEO and President

Executive Director
25,000 -9.5%
18.57
US$464,250 		25,000 -9.5% 18.57 US$464,250
2018-09-25 2018-09-25 B Purchase BURNETT JOSEPH MICHAEL

President and CEO

Executive Director
25,000 +10.8%
1.25
US$31,250 		25,000 +10.8% 1.25 US$31,250
2018-08-24 2018-08-24 B Purchase BURNETT JOSEPH MICHAEL

President and CEO

Executive Director
7,500 +3.2%
1.58
US$11,850 		7,500 +3.2% 1.58 US$11,850
2018-08-24 2018-08-22 B Purchase BURNETT JOSEPH MICHAEL

President and CEO

Executive Director
4,637 +2.0%
1.55
US$7,187 		4,637 +2.0% 1.55 US$7,187
2018-05-23 2018-05-21 B Purchase BURNETT JOSEPH MICHAEL

President and CEO

Executive Director
7,500 +1.4%
2.39
US$17,902 		7,500 +1.4% 2.39 US$17,902
2017-05-30 2017-05-26 B Purchase Jenkins Kimble L. Non-Executive Director
7,500
0.00
US$0 		7,500 0.00 US$0
2017-05-30 2017-05-26 B Purchase Grillo Francis P

CHIEF EXECUTIVE OFFICER

Executive Director
12,500
0.00
US$0 		12,500 0.00 US$0
2016-09-07 2016-09-02 B Purchase Rooke Andrew K. Non-Executive Director
10,000
0.00
US$0 		10,000 0.00 US$0
2016-09-07 2016-09-02 B Purchase Grillo Francis P

CHIEF EXECUTIVE OFFICER

Executive Director
20,000
0.00
US$0 		20,000 0.00 US$0
2014-09-15 2014-09-12 B Purchase SPENCER JOHN N JR Non-Executive Director
6,000 +400.0%
1.18
US$7,080 		6,000 +400.0% 1.18 US$7,080
2014-09-15 2014-09-12 B Purchase SPENCER JOHN N JR Non-Executive Director
10,000 +11.5%
1.18
US$11,800 		10,000 +11.5% 1.18 US$11,800
2014-08-14 2014-08-13 B Purchase SPENCER JOHN N JR Non-Executive Director
3,500 +4.2%
1.00
US$3,500 		3,500 +4.2% 1.00 US$3,500
2014-06-16 2014-06-13 B Purchase Rooke Andrew K. Non-Executive Director Large shareholder
30,000 +9.7%
0.73
US$21,900 		30,000 +9.7% 0.73 US$21,900
2014-06-12 2014-06-10 B Purchase Rooke Andrew K. Non-Executive Director Large shareholder
50,000 +19.2%
0.78
US$39,210 		50,000 +19.2% 0.78 US$39,210
2013-08-20 2013-08-19 B Purchase PIETRANGELO MICHAEL Non-Executive Director
100,000 +28.5%
1.27
US$127,000 		100,000 +28.5% 1.27 US$127,000
2013-06-12 2013-06-11 B Purchase PIETRANGELO MICHAEL Non-Executive Director
41,855 +14.1%
1.10
US$46,040 		41,855 +14.1% 1.10 US$46,040
2013-05-14 2013-05-13 B Purchase SPENCER JOHN N JR Non-Executive Director
1,500 +inf%
1.32
US$1,980 		1,500 +inf% 1.32 US$1,980
2013-03-25 2013-03-22 B Purchase Conway Bruce C. Non-Executive Director
2,500 +16.7%
1.48
US$3,700 		2,500 +16.7% 1.48 US$3,700
2013-03-21 2013-03-20 B Purchase Conway Bruce C. Non-Executive Director
2,300 +0.9%
1.50
US$3,450 		2,300 +0.9% 1.50 US$3,450
2013-03-21 2013-03-19 B Purchase Conway Bruce C. Non-Executive Director
200 +0.1%
1.49
US$298 		200 +0.1% 1.49 US$298
2013-03-18 2013-03-14 B Purchase Conway Bruce C. Non-Executive Director
5,000 +30.3%
1.50
US$7,500 		5,000 +30.3% 1.50 US$7,500
2013-03-18 2013-03-14 B Purchase Conway Bruce C. Non-Executive Director
5,000 +30.3%
1.50
US$7,500 		5,000 +30.3% 1.50 US$7,500
2013-03-18 2013-03-14 B Purchase Conway Bruce C. Non-Executive Director
5,000 +30.3%
1.50
US$7,500 		5,000 +30.3% 1.50 US$7,500
2013-03-18 2013-03-14 B Purchase Conway Bruce C. Non-Executive Director
5,000 +50.0%
1.50
US$7,500 		5,000 +50.0% 1.50 US$7,500
2013-03-18 2013-03-14 B Purchase Conway Bruce C. Non-Executive Director
3,665 +10.5%
1.46
US$5,351 		3,665 +10.5% 1.46 US$5,351
2013-03-18 2013-03-14 B Purchase Conway Bruce C. Non-Executive Director
7,500 +3.1%
1.50
US$11,250 		7,500 +3.1% 1.50 US$11,250
2013-03-18 2013-03-14 B Purchase Conway Bruce C. Non-Executive Director
1,500 +0.1%
1.49
US$2,235 		1,500 +0.1% 1.49 US$2,235
2013-03-14 2013-03-13 B Purchase Conway Bruce C. Non-Executive Director
2,000 +0.1%
1.50
US$3,000 		2,000 +0.1% 1.50 US$3,000
2013-03-12 2013-03-11 B Purchase Conway Bruce C. Non-Executive Director
10,000 +inf%
1.50
US$15,000 		10,000 +inf% 1.50 US$15,000
2013-03-12 2013-03-11 B Purchase Conway Bruce C. Non-Executive Director
10,000 +40.0%
1.56
US$15,550 		10,000 +40.0% 1.56 US$15,550
2013-03-12 2013-03-11 B Purchase Conway Bruce C. Non-Executive Director
3,500 +1.5%
1.58
US$5,526 		3,500 +1.5% 1.58 US$5,526
2013-03-12 2013-03-11 B Purchase Conway Bruce C. Non-Executive Director
5,050 +0.2%
1.55
US$7,828 		5,050 +0.2% 1.55 US$7,828
2012-09-18 2012-09-14 B Purchase Conway Bruce C. Non-Executive Director
1,000 +6.2%
2.25
US$2,250 		1,000 +6.2% 2.25 US$2,250
2012-09-18 2012-09-14 B Purchase Conway Bruce C. Non-Executive Director
1,000 +6.2%
2.27
US$2,270 		1,000 +6.2% 2.27 US$2,270
2012-09-18 2012-09-14 B Purchase Conway Bruce C. Non-Executive Director
1,000 +6.2%
2.25
US$2,250 		1,000 +6.2% 2.25 US$2,250
2012-09-18 2012-09-14 B Purchase Conway Bruce C. Non-Executive Director
1,000 +6.5%
2.00
US$2,000 		1,000 +6.5% 2.00 US$2,000
2012-09-14 2012-09-13 B Purchase Conway Bruce C. Non-Executive Director
2,500 +17.9%
2.02
US$5,050 		2,500 +17.9% 2.02 US$5,050
2012-09-14 2012-09-13 B Purchase Conway Bruce C. Non-Executive Director
2,500 +17.9%
2.00
US$5,000 		2,500 +17.9% 2.00 US$5,000
2012-09-14 2012-09-13 B Purchase Conway Bruce C. Non-Executive Director
1,500 +10.7%
2.05
US$3,075 		1,500 +10.7% 2.05 US$3,075
2012-09-14 2012-09-12 B Purchase Conway Bruce C. Non-Executive Director
2,500 +18.5%
2.05
US$5,125 		2,500 +18.5% 2.05 US$5,125
2012-09-14 2012-09-12 B Purchase Conway Bruce C. Non-Executive Director
2,500 +18.5%
2.10
US$5,250 		2,500 +18.5% 2.10 US$5,250
2012-09-14 2012-09-12 B Purchase Conway Bruce C. Non-Executive Director
2,500 +18.5%
2.08
US$5,205 		2,500 +18.5% 2.08 US$5,205
2012-09-14 2012-09-12 B Purchase Conway Bruce C. Non-Executive Director
4,750 +2.0%
2.05
US$9,738 		4,750 +2.0% 2.05 US$9,738
2012-09-12 2012-09-11 B Purchase Conway Bruce C. Non-Executive Director
5,000 +25.0%
2.05
US$10,250 		5,000 +25.0% 2.05 US$10,250
Explore more

More insider trading research around Clearpoint Neuro Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America